Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature.
Manthan KathrotiyaVivek RadhakrishnanSaurabh J BhaveArijit NagNeeraj AroraMita RoychoudhryMayur PariharDeepak MishraReena NairMammen ChandyJeevan KumarPublished in: Indian journal of cancer (2024)
Bortezomib based triplet induction regimens were effective and well tolerated in this retrospective analysis of Indian patients. We observed that AHCT effectively achieves deep and durable remission in MM.
Keyphrases
- newly diagnosed
- multiple myeloma
- end stage renal disease
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- systematic review
- stem cells
- patient reported outcomes
- cell therapy
- rheumatoid arthritis
- bone marrow
- cross sectional
- mesenchymal stem cells
- systemic lupus erythematosus
- quantum dots
- smoking cessation
- ulcerative colitis